WAKAMOTO PHARMACEUTICAL CO.,LTD. · わかもと製薬株式会社
Ownership & governance
Executives 5Directors 9Avg age 62Avg tenure 8.4y
AI
Arata Igarashi
President
Age 67Since 2022-03-31Profile →
+13
Executives5
AI
Arata Igarashi→
President
Age 67Since 2022-03-31
MT
Makoto Taniguchi→
Corporate Officer/Principal
Age 59Since 2005-06-30
HK
Hiroyoshi Kasai→
Corporate Officer/Principal
Age 58Since 2007-05-31
TH
Tomoyuki Hirai→
Corporate Officer/Principal
Age 60Since 2024-05-31
KS
Kimihiko Sato→
Chief Administrative Officer
Age 60Since 2022-03-31
Board of directors9
HH
Haruhisa Hirata
Director/Board Member
Age 69Since 2009-05-31
AI
Arata Igarashi→
Director/Board Member
Age 67Since 2011-05-31
KS
Kimihiko Sato→
Director/Board Member
Age 60Since 2019-06-20
KE
Katsuyoshi Ejima
Director/Board Member
Age 72Since 2017-05-31
TH
Tomoyuki Hirai→
Director/Board Member
Age 60Since 2023-03-31
HK
Hiroyoshi Kasai→
Director/Board Member
Age 58Since 2016-06-30
MT
Makoto Taniguchi→
Director/Board Member
Age 59Since 2024-05-31
IK
Ikuro Kuwahara
Director/Board Member
Age 69Since 2023-05-31
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| ROHTO PHARMACEUTICAL CO.,LTD. | 11.4 % | 3,971,000 |
| KISSEI PHARMACEUTICAL CO., LTD. | 10.84 % | 3,778,000 |
| Asset Value Investors Ltd. | 10.6 % | 3,693,100 |
| BRASTSHEAVE Co., Ltd. | 7.176 % | 2,500,000 |
| Wakamoto Pharmaceutical Business Association. | 5.594 % | 1,949,000 |
Catalog · 2026-07-09
Registry officers14
| Name | Role | Since | Shares |
|---|---|---|---|
| Kimihiko Sato | Chief Administrative Officer | 2022-03-31 | - |
| Arata Igarashi | President | 2022-03-31 | - |
| Hiroyoshi Kasai | Corporate Officer/Principal | 2007-05-31 | - |
| Makoto Taniguchi | Corporate Officer/Principal | 2005-06-30 | - |
| Tomoyuki Hirai | Corporate Officer/Principal | 2024-05-31 | - |
| 五十嵐 新 | 取締役会長 | 2010-05-01 | - |
| 佐藤 公彦 | 常務取締役 | 2013-04-01 | - |
| 平井 友行 | 代表取締役社長 | 2021-06-01 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.